Pfizer Inc. announced the completion of the acquisition of King Pharmaceuticals Inc. for $14.25 per share, or $3.6 billion. The deal provides Pfizer a new specialty business in pain treatments, including King's role as a critical supplier to the U.S. Department of Defense, and combines Pfizer Animal Health with King's Alpharma Animal Health, solidifying Pfizer's position as the largest animal health company in the world.
Pfizer has a broad platform in livestock, poultry, companion animal and equine drugs, and the merger adds Alpharma's specialties in feed additives and medicines for disease prevention and treatment. Pfizer Animal Health sales will exceed $4 billion per year.
About the author
As an animal lover since childhood, Flossie was delighted when Mark, the CEO and developer of EquiMed asked her to join his team of contributors.
She enrolled in My Horse University at Michigan State and completed a number of courses in everything related to horse health, nutrition, diseases and conditions, medications, hoof and dental care, barn safety, and first aid.
Staying up-to-date on the latest developments in horse care and equine health is now a habit, and she enjoys sharing a wealth of information with horse owners everywhere..